Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Dec;65(15):2016-22.
doi: 10.1016/j.addr.2013.07.013. Epub 2013 Jul 27.

Carbon nanotubes as vaccine scaffolds

Affiliations
Review

Carbon nanotubes as vaccine scaffolds

David A Scheinberg et al. Adv Drug Deliv Rev. 2013 Dec.

Abstract

Carbon nanotubes display characteristics that are potentially useful in their development as scaffolds for vaccine compositions. These features include stability in vivo, lack of intrinsic immunogenicity, low toxicity, and the ability to be appended with multiple copies of antigens. In addition, the particulate nature of carbon nanotubes and their unusual properties of rapid entry into antigen-presenting cells, such as dendritic cells, make them especially useful as carriers of antigens. Early attempts demonstrating carbon nanotube-based vaccines can be used in both infectious disease settings and cancer are promising.

Keywords: Carbon nanotubes; adjuvants; antigen presenting cells; vaccines.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Mackall CL. Spreading the wealth: Antigen discovery in adult tumors can help hone the search for pediatric tumor antigens. J. Immunother. 2001;24:281. - PubMed
    1. Farkas AM, Finn OJ. Vaccines based on abnormal self-antigens as tumor-associated antigens: Immune regulation. Semin. Immunol. 2010;22:125. - PubMed
    1. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449:419. - PubMed
    1. Melief CJM. Cancer immunotherapy by dendritic cells. Immunity. 2008;29:372. - PubMed
    1. Dyall R, Bowne WB, Weber LW, LeMaoult J, Szabo P, Moroi Y, Piskun G, Lewis JJ, Houghton AN, Nikolic-Zugic J. Heteroclitic immunization induces tumor immunity. J. Exp. Med. 1998;188:155. - PMC - PubMed

Publication types